Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kura Oncology (KURA) Net Margin (2024 - 2025)

Kura Oncology (KURA) has disclosed Net Margin for 2 consecutive years, with 467.23% as the latest value for Q4 2025.

  • On a quarterly basis, Net Margin fell 473497.0% to 467.23% in Q4 2025 year-over-year; TTM through Dec 2025 was 738.49%, a 1136017.0% decrease, with the full-year FY2025 number at 412.95%, down 9006.0% from a year prior.
  • Net Margin was 467.23% for Q4 2025 at Kura Oncology, down from 357.19% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 14974.61% in Q1 2025 to a low of 467.23% in Q4 2025.